Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HS3ST2 |
| Upstream (Parents) |
|---|
| (<<) CACNA1E → HS3ST2 |
| (<<) GPNMB → HS3ST2 |
| (<<) HCN4 → HS3ST2 |
| (<<) HSD17B2 → HS3ST2 |
| (<<) MVK → HS3ST2 |
| (<<) MYL5 → HS3ST2 |
| (<<) WNT7B → HS3ST2 |
| Downstream (Children) |
|---|
| HS3ST2 → ADAM8 (>>) |
| HS3ST2 → ALK (>>) |
| HS3ST2 → CD83 (>>) |
| HS3ST2 → COIL (>>) |
| HS3ST2 → EIF4E (>>) |
| HS3ST2 → FOXO3 (>>) |
| HS3ST2 → FZD5 (>>) |
| HS3ST2 → GRB2 (>>) |
| HS3ST2 → NFIX (>>) |
| HS3ST2 → PELO (>>) |
| HS3ST2 → PRKCA (>>) |
| HS3ST2 → VAV1 (>>) |
